These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 17696581)

  • 21. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP; Lundback B; Yigla M; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
    Kempsford R; Handel M; Mehta R; De Silva M; Daley-Yates P
    Respir Med; 2005 Apr; 99 Suppl A():S11-9. PubMed ID: 15777604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy.
    Bender BG; Hernandez Vecino RA; McGrath K; Jones S
    J Allergy Clin Immunol Pract; 2016; 4(5):884-9. PubMed ID: 27587319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database.
    Miller DP; Watkins SE; Sampson T; Davis KJ
    Phys Sportsmed; 2010 Dec; 38(4):19-27. PubMed ID: 21150138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial.
    Jõgi R; Lähelmä S; Vahteristo M; Happonen A; Haikarainen J
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):88-98. PubMed ID: 30300557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
    J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
    Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
    Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.
    Martin RM; Shakir S
    Drug Saf; 2001; 24(6):475-81. PubMed ID: 11368253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL; Noonan MJ; Weinstein SF; Chervinsky P; Scott CA; Herje NE; Wu W; Crim C
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-deposition of salmeterol and fluticasone propionate by a combination inhaler.
    Theophilus A; Moore A; Prime D; Rossomanno S; Whitcher B; Chrystyn H
    Int J Pharm; 2006 Apr; 313(1-2):14-22. PubMed ID: 16516417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.
    Twaites BR; Wilton LV; Shakir SA
    Drug Saf; 2007; 30(5):419-29. PubMed ID: 17472420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Yates JC; Vestbo J;
    N Engl J Med; 2007 Feb; 356(8):775-89. PubMed ID: 17314337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
    J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.